Ixaltis
Business Services · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
60 Avenue Marie Curie, Archamps, Auvergn...Phone Number
+33 457260076Website
www.ixaltis.comRevenue
$7.3 MillionIndustry
ZI Rank: 1
About Ixaltis
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ixaltis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Ixaltis has recently received funding, and reach out quickly before it becomes old news!
Ixaltis, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Ixaltis is spiking on competitors!
Earning: See what the market has to say on Ixaltis recently announced quarterly report
Product Launch: Get notified when Ixaltis launches new products
Funding: Get notified immidiatlly once Ixaltis has new funding data
Click to see if Ixaltis had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Ixaltis
Recommended Actions
Find VP level buyers at Ixaltis
Find more new buyers
Company Profile Activity
Activity Insights
Ixaltis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ixaltis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ixaltis.
Ixaltis financials insights
Gather financial insights about Ixaltis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$8.9M
Ixaltis Tech Stack
A closer look at the technologies used by Ixaltis
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ixaltis
IXALTIS, SA with capital of 538 784, is specialized in Genitourinary and kidney disease, with their primary activity in experimental research and development of innovative compounds. IXALTIS has acquired rights to three molecules, including Litoxetine (IXA-001) under exclusive license from Sanofi. The first pre-clinical trials, conducted by private... Read More
